The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.
By Richard G. Moore, Amy K. Brown, M. Miller, S. Skates, W. Allard, T. Verch, M. Steinhoff, G. Messerlian, P. DiSilvestro, C. Granai and 1 more. Gynecologic Oncology, 2008
720 citations recorded by the source corpus.
Subfields: Obstetrics and Gynecology, Reproductive Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/47efa224233f5f28ccb1eb166c328b6f6e84de96
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Obstetrics and Gynecology
In Reproductive Medicine
Citations in the corpus
- A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass. (2009, background): “Equally important, a combination of HE4 and CA125 or HE4 alone has been shown to have greater sensitivity in patients with early stage disease compared with CA125 [11].”